Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.
Also called NCT04183257
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 106 participants
- Registry
-
NCT04183257
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT04183257. Randomized; no masking; primary purpose treatment. Start 2016-09-30 (actual); primary completion 2017-04-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
- Condition
- Vitamin D Deficiency
- Condition
- Insulin Resistance
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- oral vitamin D
- Lead sponsor
- King Edward Medical University
Record details
- Record id
cardio:ct-nct04183257- Content hash
a04feaddc3eed653f9c7335dc45a3f6592410856289c87ca0434dc2ab60f2331